GBP3 and metabolic dysfunction-associated steatotic liver disease: These pathways coordinate the progression of NAFLD by regulating key inflammatory-acting genes such as Ccl6, Gas6, Gbp3, Slc11a1, and others that are involved in the IFN response and are known to drive NAFLD [36].